Assessment of defects and amorphous structure produced in raffinose pentahydrate upon dehydration. 2007

Simon Bates, and Ron C Kelly, and Igor Ivanisevic, and Paul Schields, and George Zografi, and Ann W Newman
SSCI, Inc., West Lafayette, Indiana 47906, USA.

The progressive conversion of crystalline raffinose pentahydrate to its amorphous form by dehydration at 60 degrees C, well below its melting temperature, was monitored by X-ray powder diffraction over a period of 72 h. The presence of defects within the crystal structure and any amorphous structure created was determined computationally by a total diffraction method where both coherent long-range crystalline order and incoherent short-range disorder components were modeled as a single system. The data were analyzed using Rietveld, pair distribution function (PDF), and Debye total diffraction methods. Throughout the dehydration process, when crystalline material was observed, the average long-range crystal structure remained isostructural with the original pentahydrate material. Although the space group symmetry remained unchanged by dehydration, the c-axis of the crystal unit cell exhibited an abrupt discontinuity after approximately 2 h of drying (loss of one to two water molecules). Analysis of diffuse X-ray scattering revealed an initial rapid build up of defects during the first 0.5 h with no evidence of any amorphous material. From 1-2 h of drying out to 8 h where the crystalline structure is last observed, the diffuse scattering has both amorphous and defect contributions. After 24 h of drying, there was no evidence of any crystalline material remaining. It is concluded that the removal of the first two waters from raffinose pentahydrate created defects, likely in the form of vacancies, that provided the thermodynamic driving force and disorder for subsequent conversion to the completely amorphous state.

UI MeSH Term Description Entries
D008956 Models, Chemical Theoretical representations that simulate the behavior or activity of chemical processes or phenomena; includes the use of mathematical equations, computers, and other electronic equipment. Chemical Models,Chemical Model,Model, Chemical
D008958 Models, Molecular Models used experimentally or theoretically to study molecular shape, electronic properties, or interactions; includes analogous molecules, computer-generated graphics, and mechanical structures. Molecular Models,Model, Molecular,Molecular Model
D008968 Molecular Conformation The characteristic three-dimensional shape of a molecule. Molecular Configuration,3D Molecular Structure,Configuration, Molecular,Molecular Structure, Three Dimensional,Three Dimensional Molecular Structure,3D Molecular Structures,Configurations, Molecular,Conformation, Molecular,Conformations, Molecular,Molecular Configurations,Molecular Conformations,Molecular Structure, 3D,Molecular Structures, 3D,Structure, 3D Molecular,Structures, 3D Molecular
D011208 Powders Substances made up of an aggregation of small particles, as that obtained by grinding or trituration of a solid drug. In pharmacy it is a form in which substances are administered. (From Dorland, 28th ed) Powder
D011887 Raffinose A trisaccharide occurring in Australian manna (from Eucalyptus spp, Myrtaceae) and in cottonseed meal. Gossypose,Melitose,Melitriose
D002626 Chemistry, Pharmaceutical Chemistry dealing with the composition and preparation of agents having PHARMACOLOGIC ACTIONS or diagnostic use. Medicinal Chemistry,Chemistry, Pharmaceutic,Pharmaceutic Chemistry,Pharmaceutical Chemistry,Chemistry, Medicinal
D003460 Crystallization The formation of crystalline substances from solutions or melts. (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Crystalline Polymorphs,Polymorphism, Crystallization,Crystal Growth,Polymorphic Crystals,Crystal, Polymorphic,Crystalline Polymorph,Crystallization Polymorphism,Crystallization Polymorphisms,Crystals, Polymorphic,Growth, Crystal,Polymorph, Crystalline,Polymorphic Crystal,Polymorphisms, Crystallization,Polymorphs, Crystalline
D003890 Desiccation Removal of moisture from a substance (chemical, food, tissue, etc.). Dessication
D004339 Drug Compounding The preparation, mixing, and assembly of a drug. (From Remington, The Science and Practice of Pharmacy, 19th ed, p1814). Drug Formulation,Drug Preparation,Drug Microencapsulation,Pharmaceutical Formulation,Compounding, Drug,Formulation, Drug,Formulation, Pharmaceutical,Microencapsulation, Drug,Preparation, Drug
D013678 Technology, Pharmaceutical The application of scientific knowledge or technology to pharmacy and the pharmaceutical industry. It includes methods, techniques, and instrumentation in the manufacture, preparation, compounding, dispensing, packaging, and storing of drugs and other preparations used in diagnostic and determinative procedures, and in the treatment of patients. Technology, Pharmacy,Pharmaceutic Technology,Pharmaceutical Technology,Pharmacy Technology,Technology, Pharmaceutic

Related Publications

Simon Bates, and Ron C Kelly, and Igor Ivanisevic, and Paul Schields, and George Zografi, and Ann W Newman
November 2015, Acta crystallographica. Section C, Structural chemistry,
Simon Bates, and Ron C Kelly, and Igor Ivanisevic, and Paul Schields, and George Zografi, and Ann W Newman
March 1970, Acta crystallographica. Section B: Structural crystallography and crystal chemistry,
Simon Bates, and Ron C Kelly, and Igor Ivanisevic, and Paul Schields, and George Zografi, and Ann W Newman
October 1990, Carbohydrate research,
Simon Bates, and Ron C Kelly, and Igor Ivanisevic, and Paul Schields, and George Zografi, and Ann W Newman
March 1995, Journal of pharmaceutical sciences,
Simon Bates, and Ron C Kelly, and Igor Ivanisevic, and Paul Schields, and George Zografi, and Ann W Newman
July 2005, Pharmaceutical research,
Simon Bates, and Ron C Kelly, and Igor Ivanisevic, and Paul Schields, and George Zografi, and Ann W Newman
June 2010, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences,
Simon Bates, and Ron C Kelly, and Igor Ivanisevic, and Paul Schields, and George Zografi, and Ann W Newman
March 2001, International journal of pharmaceutics,
Simon Bates, and Ron C Kelly, and Igor Ivanisevic, and Paul Schields, and George Zografi, and Ann W Newman
December 2006, Journal of pharmaceutical sciences,
Simon Bates, and Ron C Kelly, and Igor Ivanisevic, and Paul Schields, and George Zografi, and Ann W Newman
October 1993, Acta crystallographica. Section C, Crystal structure communications,
Simon Bates, and Ron C Kelly, and Igor Ivanisevic, and Paul Schields, and George Zografi, and Ann W Newman
June 1992, Physical review. B, Condensed matter,
Copied contents to your clipboard!